Noema Pharma
Treatment developer for central nervous system (CNS) disorders patient.
3
Funding Rounds
$317.0m
Money raised
Overview
Treatment developer for central nervous system (CNS) disorders patient.
- Website:
- Business model: B2B
- Headquarters: Basel
- Social accounts: linkedin
Funding
Funding series
Funding Series Analysis
The company Noema Pharma has raised a total of $257m in funding over 3 rounds.
Key Insights:
- Noema Pharma Series B Round, December 2024: $147m
- Noema Pharma March 2023 Series B Funding Round: $110m
- Noema Pharma Series A round December 2020: $60m
Noema Pharma Series B Round, December 2024
$147m
Noema Pharma March 2023 Series B Funding Round
$110m
Noema Pharma Series A round December 2020
$60m
Industries
Noema Pharma is active in the following industries: